AMY MULLIN: Open Payments
NPI 1619572823 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,169 in 108 payments from 28 companies in 2025. Trend: 2023 $1,935 · 2024 $2,026 · 2025 $2,169
Food & beverage: $2,169
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $312 |
| Lilly USA, LLC | 18 | $265 |
| Tandem Diabetes Care, Inc. | 11 | $172 |
| Corcept Therapeutics | 10 | $158 |
| CeQur Corporation | 1 | $153 |
| Ascendis Pharma Endocrinology Inc | 2 | $131 |
| Madrigal Pharmaceuticals | 4 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
Products named: Ozempic, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, Korlym, CeQur Simplicity, Yorvipath, REZDIFFRA, JARDIANCE.
Industry payments across IN — which companies pay providers there.
